DK0938501T3 - Fremgangsmåde til oprensning af human interleukin-1 receptorantagonist fra rekombinant E. coli - Google Patents

Fremgangsmåde til oprensning af human interleukin-1 receptorantagonist fra rekombinant E. coli

Info

Publication number
DK0938501T3
DK0938501T3 DK97923960T DK97923960T DK0938501T3 DK 0938501 T3 DK0938501 T3 DK 0938501T3 DK 97923960 T DK97923960 T DK 97923960T DK 97923960 T DK97923960 T DK 97923960T DK 0938501 T3 DK0938501 T3 DK 0938501T3
Authority
DK
Denmark
Prior art keywords
recombinant
value
receptor antagonist
human interleukin
ionic strength
Prior art date
Application number
DK97923960T
Other languages
Danish (da)
English (en)
Inventor
Dino Zanette
Edoardo Giacomo Sarubbi
Adolfo Soffientini
Original Assignee
Aventis Bulk S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Bulk S P A filed Critical Aventis Bulk S P A
Application granted granted Critical
Publication of DK0938501T3 publication Critical patent/DK0938501T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97923960T 1996-06-07 1997-05-21 Fremgangsmåde til oprensning af human interleukin-1 receptorantagonist fra rekombinant E. coli DK0938501T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96109153 1996-06-07
EP97923960A EP0938501B1 (en) 1996-06-07 1997-05-21 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli

Publications (1)

Publication Number Publication Date
DK0938501T3 true DK0938501T3 (da) 2004-11-15

Family

ID=8222862

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97923960T DK0938501T3 (da) 1996-06-07 1997-05-21 Fremgangsmåde til oprensning af human interleukin-1 receptorantagonist fra rekombinant E. coli

Country Status (11)

Country Link
EP (1) EP0938501B1 (pt)
JP (1) JP2000512143A (pt)
AT (1) ATE272072T1 (pt)
AU (1) AU717003B2 (pt)
CA (1) CA2257294C (pt)
DE (1) DE69730041T2 (pt)
DK (1) DK0938501T3 (pt)
ES (1) ES2221688T3 (pt)
IL (1) IL127155A (pt)
PT (1) PT938501E (pt)
WO (1) WO1997047650A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927801D0 (en) * 1999-11-24 2000-01-26 Danisco Method
WO2001041792A1 (en) * 1999-12-10 2001-06-14 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US20080166762A1 (en) * 2006-09-27 2008-07-10 Reliance Life Science Pvt.Ltd. HETEROLOGOUS PRODUCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST (IL-1Ra) IN PICHIA PASTORIS
AU2008207207B2 (en) 2007-01-15 2012-10-18 Upfront Chromatography A/S Production of biofuel and protein from a raw material
DE202007002869U1 (de) 2007-02-27 2008-07-10 Ds Dichtungstechnik Gmbh Dichtring und Steckmuffenverbindung
SG10201606218WA (en) * 2011-07-29 2016-09-29 Eleven Biotherapeutics Inc Purified Proteins
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
AU2019332100A1 (en) 2018-08-29 2021-03-18 Merck Biodevelopment S.A.S. New purification method

Also Published As

Publication number Publication date
DE69730041T2 (de) 2005-07-21
ES2221688T3 (es) 2005-01-01
IL127155A0 (en) 1999-09-22
CA2257294C (en) 2006-03-14
CA2257294A1 (en) 1997-12-18
EP0938501B1 (en) 2004-07-28
IL127155A (en) 2007-05-15
JP2000512143A (ja) 2000-09-19
EP0938501A1 (en) 1999-09-01
ATE272072T1 (de) 2004-08-15
WO1997047650A1 (en) 1997-12-18
DE69730041D1 (de) 2004-09-02
AU2958697A (en) 1998-01-07
AU717003B2 (en) 2000-03-16
PT938501E (pt) 2004-11-30

Similar Documents

Publication Publication Date Title
US6399333B1 (en) Process for producing erythropoietin containing no animal proteins
Jamieson Jr et al. Calcium-dependent affinity chromatography of calmodulin on an immobilized phenothiazine
Kerlavage et al. Covalent modification of an adenosine 3': 5'-monophosphate binding site of the regulatory subunit of cAMP-dependent protein kinase II with 8-azidoadenosine 3': 5'-monophosphate. Identification of a single modified tyrosine residue.
AU698334B2 (en) Method for isolation of highly pure von willebrand factor
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
AU2671795A (en) Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
IE860305L (en) Method for purifying antihemophilic factor
AU7575487A (en) Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies
EP0318296A3 (en) Interleukin-1 receptors
CY1108175T1 (el) ΠΟΛΥΠΕΠΤΙΔΙΟ DcR3, ΟΜΟΛΟΓΟ TNFR
YU50502A (sh) Postupak za prečišćavanje farmakološki aktivnih proteina pomoću katjonske izmenjivačke hromatografije
WO1995019570B1 (en) Antagonists to insulin receptor tyrosine kinase inhibitor
AU5020296A (en) C-C chemokine receptor 3: CKR-3 or EOS-l2
NZ504752A (en) Hydrophobically-modified protein compositions (particularly hedgehog proteins)
WO1995009872B1 (en) Dna encoding prostaglandin receptor ip
EP0960622A3 (en) Use of pharmaceutical compositions containing both IL-6 and IL-12 for the activation of T cells
WO1996033730A3 (en) Chemokine binding protein and methods of use therefor
DK0938501T3 (da) Fremgangsmåde til oprensning af human interleukin-1 receptorantagonist fra rekombinant E. coli
PT759942E (pt) Receptor de interleucina-15
CA2209858A1 (en) Il-2r-associated polypeptide and dna molecules coding therefor
IE801589L (en) Homogenous fibroblast interferon
MY125980A (en) Highly purified cytokine activating factor and methods of use
WO1995000552B1 (en) Prostaglandin receptor ep3 and dna encoding it
AU2002222658A1 (en) Novel aggrecanase
AU7508694A (en) Novel tyrosine kinase